Stay informed with the latest litigation news. Explore now

IP Verse

Galenicum Health Slu competitive analysis

Latest publications and patents of Galenicum Health Slu New

Explore the latest publications and patents granted to Galenicum Health Slu, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Galenicum Health Slu

EP3512505
Mar 15, 2023Vildagliptin Pharmaceutical CompositionsGranted And Under Opposition
EP3240529
Feb 2, 2022Stable Pharmaceutical Compositions Comprising MicafunginGranted And Under Opposition
EP2915526
Jun 2, 2021Pharmaceutical Compositions Comprising AnagrelideGranted And Under Opposition
EP3102187
Mar 25, 2020Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release TabletsRevoked

Latest oppositions filed by Galenicum Health Slu

Explore patent oppositions filed by Galenicum Health Slu against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3090730
Novel Pharmaceutical CompositionNOVARTISJan 9, 2025
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024
EP3270909
Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular RiskESPERION THERAPEUTICSJul 31, 2024
EP3634463
Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALSJun 27, 2024
EP3810201
Gip/Glp1 Agonist CompositionsELI LILLYMar 7, 2024
EP2508188
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateASTRAZENECAFeb 9, 2024
EP3191461
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022
EP2863895
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 14, 2022
EP3431475
Solid Forms Of A Selective Cdk4/6 InhibitorPFIZERJan 7, 2022
EP2797581
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEFeb 8, 2021

Latest patents of Galenicum Health Slu opposed by its competitors

Explore Galenicum Health Slu's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3512505
Mar 15, 2023Vildagliptin Pharmaceutical Compositions2
EP3240529
Feb 2, 2022Stable Pharmaceutical Compositions Comprising Micafungin2
EP2915526
Jun 2, 2021Pharmaceutical Compositions Comprising Anagrelide1
EP3102187
Mar 25, 2020Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets7

Latest PTAB cases involving Galenicum Health Slu New

Discover the latest PTAB cases involving Galenicum Health Slu, highlighting their recent legal challenges and patent disputes.